Hybio Pharmaceutical Co., Ltd. (SHE:300199)
23.65
-0.27 (-1.13%)
May 20, 2026, 11:35 AM CST
67.14% (1Y)
| Market Cap | 21.13B +86.1% |
| Revenue (ttm) | 955.53M +27.4% |
| Net Income | 94.52M |
| EPS | 0.10 |
| Shares Out | 883.24M |
| PE Ratio | 233.88 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 31,699,046 |
| Average Volume | 54,109,043 |
| Open | 23.00 |
| Previous Close | 23.92 |
| Day's Range | 22.85 - 24.02 |
| 52-Week Range | 13.46 - 31.19 |
| Beta | 0.76 |
| RSI | 63.65 |
| Earnings Date | Apr 29, 2026 |